Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor In the systematic review of breast cancer screening, Dr Myers and colleagues1 claimed that our Cochrane review2 showed that breast screening reduces cause-specific mortality by 19%, there was no significant heterogeneity, and our results were similar to those of other reviews. This misrepresents our findings and creates an impression of scientific agreement that does not exist.
Jørgensen KJ, Gøtzsche PC. Breast Cancer Screening: Benefit or Harm?. JAMA. 2016;315(13):1402. doi:10.1001/jama.2015.19126